<DOC>
	<DOCNO>NCT01849380</DOCNO>
	<brief_summary>S-1 newly develop novel oral dihydrouracil dehydrogenase inhibit fluoro-pyrimidine drug consist M tegafur ( FT ) , 0.4 M 5-chloro-2 , 4-dihydroxypyrimidine ( gimeracil ) , 1 M potassium oxonate ( oteracil ) , efficient antitumor activity low gastrointestinal toxicity . Several study prove safety efficacy single agent S-1 metastatic breast cancer . This study design investigate compare efficacy safety Epirubicin-cyclophosphamide-S-1 ( ECS ) vs. Epirubicin-cyclophosphamide-5-fluorouracil ( ECF ) neoadjuvant chemotherapy patient local advance breast cancer .</brief_summary>
	<brief_title>Neoadjuvant ECS Versus ECF Local Advanced Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Epirubicin</mesh_term>
	<criteria>Disease characteristic : Histologically confirm primary breast cancer core biopsy ( Mammotome bard needle ) Disease stage appropriate neoadjuvant chemotherapy ( T≥3cm , N0 T（23cm）N1 T , N2 ) Her2 ( ) ; Ki67≥14 % No previous treatment breast cancer ( chemotherapy , endocrinotherapy , radiotherapy ) Patients characteristic : Female patient , age 18 70 year old Performance Status Eastern Cooperative Oncology Group ( ECOG ) 02 Life expectancy least 12 week Willing keep followup Functions maintain major organ : Cardiac status : LVEF : 50 % 45 % • Haematopoietic status : Leukocyte count : ≥4.0×109/L Neutrophil count : ≥2.0×109/L Platelet count : ≥100×109/L Hemoglobin : ≥80g/L • Hepatic status : Total Bilirubin ≤ 1.5 x upper limit normal ( ULN ) , AST ALT ≤ 2.5 time ULN ( liver metastasis ) bilirubin : • Renal status : BUN ≤ 1.5 x time ULN Creatinine ≤1.5 time ULN calculate creatinine clearance , use CockcroftGault formula , ≥50 mL/min ; Women 's Ccr = Body weight x ( 140Age ) / ( 72 x Serum creatinine ) x 0.85 • Written inform consent ( biopsy neoadjuvant chemotherapy ) obtain patient enter study Previous treatment breast cancer ( neither local systemic therapy ) Known suspect distant metastasis Potentially pregnant , pregnant , breastfeed Drug allergy Concurrent malignancy history malignancy ( except Hodgkin lymphoma ) Currently active severe infection ( Hepatitis include ) History significant neurological psychiatric disorder include psychotic disorder , dementia seizure Known history uncontrolled severe heart disease , myocardial infarction within 6 month , congestive heart failure , unstable angina pectoris , clinically significant hydropericardium unstable arrhythmia</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Local Advanced Breast Neoplasms</keyword>
	<keyword>Neoadjuvant Chemotherapy</keyword>
	<keyword>S-1</keyword>
</DOC>